Recent reports link weight loss drugs Ozempic and Mounjaro to severe vision loss. With cases of blindness emerging, medical experts urge further research to understand the risks affecting millions of ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS candidate RFK Jr told senators the GLP-1s are ‘miracle drugs’ but shouldn’t ...

Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews ...

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can cause irreversible damage and permanent vision loss, including total ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.